Core Insights - The company reported net sales of €1.62 billion, driven by growth in Composite Materials, Technology Solutions, and Novecare, with a resilient underlying EBITDA of €311 million, reflecting a 5% sequential increase [1][3][5] Financial Performance - Net sales for Q1 2025 were €1,619 million, showing a slight decrease of 0.3% year-on-year and an increase of 1.3% sequentially [2][5] - Gross profit was €514 million, down 11.9% year-on-year, with a gross profit margin of 31.7%, which is a decrease of 420 basis points year-on-year but an increase of 160 basis points sequentially [2][5] - Underlying EBITDA decreased by 14.2% year-on-year to €311 million, with an underlying EBITDA margin of 19.2%, down 310 basis points year-on-year but up 60 basis points sequentially [2][5] - Operating cash flow was €176 million, while free cash flow was €37 million, impacted by capital expenditures [2][5] Market Outlook - The company maintains its outlook for FY 2025, expecting continued macroeconomic and demand uncertainty due to ongoing tariff and global trade tensions [4][6] - The second quarter of 2025 is anticipated to have challenging visibility, with demand uncertainty expected to persist across most end markets [9][10] - The company plans to accelerate restructuring and cost-saving initiatives, including a proposed reduction of approximately 200 positions, aiming for over €200 million in run rate savings by the end of 2026 [8][10] Strategic Initiatives - The company is implementing mitigation measures to manage direct exposures to tariff impacts, including tariff surcharges and refining supply chain exposures [7] - The focus remains on executing controllable initiatives, such as completing separation processes and making disciplined, high-return investments [4][6]

Core Viewpoint - Syensqo has revised its segment reporting structure to better align with its strategic focus, particularly in light of its intention to divest from the Oil & Gas and Aroma Performance business units [1][2]. Group 1: Segment Reporting Changes - The new segment reporting structure will include four reportable segments: Materials, Performance & Care, Other Solutions, and Corporate & Business Services, effective from Q1 2025 [2][4]. - The previously reported financial information for fiscal year 2024 has been recast to reflect these new segments, although this change does not impact the previously reported consolidated financial statements [2][3]. Group 2: Segment Descriptions - The Materials segment will continue to consist of Specialty Polymers and Composite Materials, focusing on high-performance polymers and composite technologies for sustainable mobility applications [4]. - Performance & Care, previously known as Consumer & Resources, will now include Novecare and Technology Solutions, emphasizing sustainability and enhanced performance in various applications [4]. - Other Solutions will combine Aroma Performance and Oil & Gas, with Aroma Performance being a leader in synthetic and natural vanillin production and Oil & Gas providing tailored solutions for the upstream oilfield sector [4]. - Corporate & Business Services will encompass corporate functions and other business services, including research & innovation and new business development [4].